ORGS
Orgenesis Inc. Common Stock
ORGS
ORGS
Delisted
ORGS was delisted on the 18th of October, 2024.
20 hedge funds and large institutions have $3.02M invested in Orgenesis Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
80% less call options, than puts
Call options by funds: $1K | Put options by funds: $5K
Holders
20
Holding in Top 10
–
Calls
$1K
Puts
$5K
Top Buyers
| 1 | +$29.9K | |
| 2 | +$14K | |
| 3 | +$10.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.69K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.1K |
Top Sellers
| 1 | -$42K | |
| 2 | -$6.85K | |
| 3 | -$564 | |
| 4 |
Morgan Stanley
New York
|
-$546 |
| 5 |
Barclays
London,
United Kingdom
|
-$38 |